- Today
- Holidays
- Birthdays
- Reminders
- Cities
- Atlanta
- Austin
- Baltimore
- Berwyn
- Beverly Hills
- Birmingham
- Boston
- Brooklyn
- Buffalo
- Charlotte
- Chicago
- Cincinnati
- Cleveland
- Columbus
- Dallas
- Denver
- Detroit
- Fort Worth
- Houston
- Indianapolis
- Knoxville
- Las Vegas
- Los Angeles
- Louisville
- Madison
- Memphis
- Miami
- Milwaukee
- Minneapolis
- Nashville
- New Orleans
- New York
- Omaha
- Orlando
- Philadelphia
- Phoenix
- Pittsburgh
- Portland
- Raleigh
- Richmond
- Rutherford
- Sacramento
- Salt Lake City
- San Antonio
- San Diego
- San Francisco
- San Jose
- Seattle
- Tampa
- Tucson
- Washington
Neonc Technologies President Buys 20,000 Shares
Insider purchase represents 0.67% increase in ownership stake
Apr. 7, 2026 at 8:36am
Got story updates? Submit your updates here. ›
An insider's purchase of Neonc Technologies stock suggests confidence in the company's cutting-edge medical research and development.Los Angeles TodayNeonc Technologies Holdings, Inc. (NASDAQ:NTHI) President Amir Heshmatpour acquired 20,000 shares of the company's stock in a transaction on Thursday, April 2nd. The shares were purchased at an average cost of $6.09 per share, for a total value of $121,800. Following the transaction, Heshmatpour now owns 3,012,000 shares of the company, valued at approximately $18,343,080.
Why it matters
Insider buying can be seen as a positive signal, as it suggests the company's leadership has confidence in the business and its future prospects. This purchase represents a 0.67% increase in Heshmatpour's ownership stake, indicating his belief in the company's potential.
The details
The stock purchase was disclosed in a filing with the SEC. Neonc Technologies is a biopharmaceutical company developing novel molecular technologies for treating central nervous system diseases, including glioblastoma and other conditions.
- The transaction took place on Thursday, April 2nd, 2026.
The players
Amir Heshmatpour
President of Neonc Technologies Holdings, Inc.
Neonc Technologies Holdings, Inc.
A biopharmaceutical company developing novel molecular technologies for treating central nervous system diseases.
What’s next
Investors will likely be watching to see if Heshmatpour or other Neonc Technologies insiders make additional purchases, which could signal continued confidence in the company's prospects.
The takeaway
Insider buying, especially by a company's president, can be a positive sign for investors as it suggests the leadership team believes the stock is undervalued. This purchase by Heshmatpour represents a meaningful increase in his ownership stake and could indicate his belief in Neonc Technologies' long-term potential.
Los Angeles top stories
Los Angeles events
Apr. 7, 2026
Monty Python's Spamalot (Touring)Apr. 7, 2026
Los Angeles Lakers vs. Oklahoma City ThunderApr. 7, 2026
Dark Tranquillity & Soen




